Sort
21,281 grants matching “influenza”
Role of SFTPC in Pathogenesis of Interstitial Lung Disease
$448,249Timothy Edward Weaver · Cincinnati Childrens Hosp Med Ctr · R01 · FY2010 · HL
Mechanisms by Which Influenza A Protects Against Asthma
$448,015Dale T Umetsu · Boston Children'S Hospital · R01 · FY2007 · AI
Maternal flu infection and brain development in primates
$448,012Christopher L. Coe · University Of Wisconsin-Madison · R01 · FY2010 · AI
Universal Influenza Matrix 2 Subunit Vaccine
$447,851Molecular Express, Inc. · R43 · FY2004 · AI
Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array
$447,801Erik F. Young · Quicksilver Biosciences, Inc. · R44 · FY2022 · DE
Vaccine development and production
$447,748Sylvain Fleury · University Of Louisiana At Lafayette · U19 · FY2019 · AI
Project 3: Effects of Age on Cellular, Transcriptomic and Biochemical Influenza Signatures
$447,721Albert C Shaw · Yale University · U19 · FY2017 · AI
Manipulating collectivity and Niches for Developing CD8 Immunity
$447,712Matthew F Krummel · University Of California, San Francisco · R01 · FY2019 · AI
Manipulating collectivity and Niches for Developing CD8 Immunity
$447,669Matthew F Krummel · University Of California, San Francisco · R01 · FY2017 · AI
Lipid/DNA/Antigen Complexes for Influenza A Viral Vaccination
$447,587Jeff C Fairman · Juvaris Biotherapeutics, Inc. · R41 · FY2006 · AI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses
$447,570Carmen Molina-Paris · Triad National Security, Llc · R01 · FY2025 · AI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses
$447,570Carmen Molina-Paris · Triad National Security, Llc · R01 · FY2022 · AI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses
$447,570Carmen Molina-Paris · Triad National Security, Llc · R01 · FY2024 · AI
US-UK Collab: Modelling reassortment at the cellular, clinical, and phylogenetic level in emerging Bunyaviruses
$447,570Carmen Molina-Paris · Triad National Security, Llc · R01 · FY2023 · AI
Molecular Mechanism of Folding of Nsp12 and Assembly of the SARS-CoV-2 RNA Polymerase Complex by the Cytosolic Chaperonin CCT
$447,548Barry M Willardson · Brigham Young University · R15 · FY2024 · GM
Supplement: Immunometabolic and epigenetic effects of obesity on innate immune surveillance in cancer
$447,500Lydia Lynch · Brigham And Women'S Hospital · R01 · FY2020 · AI
The Non-Inflammasome NLRs in Immunity and Host defense
$447,500Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2016 · AI
Modeling B Cell Vaccine Responses in Transplant Recipients
$447,472Martin S Zand · University Of Rochester · R01 · FY2012 · AI
TNFR Members in T Cell Immunity to Vaccinia
$447,467Michael Croft · La Jolla Institute For Immunology · R01 · FY2010 · AI
Balancing protection versus immunopathology by RSV-specific memory CD8 T cells
$447,448Steven M Varga · University Of Iowa · R01 · FY2018 · AI
P2: Defining and Visualizing Effects of Costimulation on Antiviral Immunity
$447,374Arlene H Sharpe · Harvard Medical School · P01 · FY2017 · AI
Core C - Modeling Core
$447,342Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Manipulating collectivity and Niches for Developing CD8 Immunity
$447,331Matthew F Krummel · University Of California, San Francisco · R01 · FY2016 · AI
Mechanistic evaluation of broccoli sprout extract in preclinical COPD models
$447,214Shyam Biswal · Johns Hopkins University · R01 · FY2014 · AT
Carbohydrate-based Antiinfective Agents
$447,189Chi-Huey Wong · Scripps Research Institute, The · R01 · FY2008 · AI